Glaukos Cash on Hand 2014-2024 | GKOS
Glaukos cash on hand from 2014 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- Glaukos cash on hand for the quarter ending September 30, 2024 was $0.262B, a 12.76% decline year-over-year.
- Glaukos cash on hand for 2023 was $0.295B, a 16.24% decline from 2022.
- Glaukos cash on hand for 2022 was $0.353B, a 14.82% decline from 2021.
- Glaukos cash on hand for 2021 was $0.414B, a 2.39% increase from 2020.
| Glaukos Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $295 |
| 2022 | $353 |
| 2021 | $414 |
| 2020 | $404 |
| 2019 | $174 |
| 2018 | $140 |
| 2017 | $119 |
| 2016 | $96 |
| 2015 | $91 |
| 2014 | $2 |
| 2013 | $7 |
| Glaukos Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-09-30 | $262 |
| 2024-06-30 | $262 |
| 2024-03-31 | $273 |
| 2023-12-31 | $295 |
| 2023-09-30 | $301 |
| 2023-06-30 | $304 |
| 2023-03-31 | $318 |
| 2022-12-31 | $353 |
| 2022-09-30 | $362 |
| 2022-06-30 | $391 |
| 2022-03-31 | $415 |
| 2021-12-31 | $414 |
| 2021-09-30 | $429 |
| 2021-06-30 | $419 |
| 2021-03-31 | $407 |
| 2020-12-31 | $404 |
| 2020-09-30 | $388 |
| 2020-06-30 | $395 |
| 2020-03-31 | $164 |
| 2019-12-31 | $174 |
| 2019-09-30 | $153 |
| 2019-06-30 | $150 |
| 2019-03-31 | $145 |
| 2018-12-31 | $140 |
| 2018-09-30 | $138 |
| 2018-06-30 | $120 |
| 2018-03-31 | $114 |
| 2017-12-31 | $119 |
| 2017-09-30 | $109 |
| 2017-06-30 | $104 |
| 2017-03-31 | $99 |
| 2016-12-31 | $96 |
| 2016-09-30 | $94 |
| 2016-06-30 | $94 |
| 2016-03-31 | $88 |
| 2015-12-31 | $91 |
| 2015-09-30 | $93 |
| 2015-06-30 | $104 |
| 2015-03-31 | $4 |
| 2014-12-31 | $2 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $7 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.631B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |